Port Erin Biopharma Investments Ltd (LSE:PEBI) - Share price - Overview

Stock Report

Port Erin Biopharma Investments Ltd PEBI

Last Price
GBX4.88

Day Change
-0.13|-2.50%

As of 31/10/2017
10:43:17 GMT | GBX
Minimum 15 Minutes Delay.

Last Close5.00p
Day Range4.63 - 4.63
Mkt Cap1.13Mil
52-Wk Range4.25 - 9.25
Yield %0.00
ISINIM00B6QH1J21
Volume9,461
P/E-2.12
P/SInfinity
P/CF-5.98

Share Price

Total Returns 24/11/2017

 Chg (%)  
More ...
Port Erin Biopharma Investments Ltd0.00 
FTSE 100 TR GBP-0.98
 
Financials
201420152016
More ...
Income Statement
Turnover2.100.000.00
Operating Profit1.38-0.60-0.53
Net Profit1.38-0.60-0.53
Reported EPS4.08-2.03-2.30
Balance Sheet
Current Assets5.382.722.21
Non Current Assets0.000.000.00
Total Assets5.382.722.21
Current Liabilities0.400.030.05
Total Liabilities0.400.030.05
Total Equity4.982.692.15
Cash Flow
Operating Cash Flow-0.27-0.80-0.19
Net Change in Cash-0.09-0.31-0.24
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------

Company Profile

Port Erin Biopharma Investments Ltd invests in biopharmaceutical sector. Its objective is to create value for shareholders through investing in companies that have potential to generate substantial revenues through development of biopharmaceutical drugs.

Sector

Biotechnology

Market Position

1802 of 1834 Companies

Index

FTSE AIM All Share

Outlook

(29/03/2017) ch - "The company's investments continue to show significant growth potential for the remainder of 2017 and beyond"

Next Event 22/12/2017

Next annual report due
Ratios
CompSecMkt
More ...
PER (E)0.0013.5516.24
Div Yld (E)0.004.114.26
PEG (E)0.001.481.30
ROCE-24.81179.8815.14
Op Mrgn0.00-7.94-1.61
EPS Grwth0.0011.9213.31
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanJim Mellon
Finance DirectorMr. Denham Eke
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.